GLS and head and neck squamous cell carcinoma: Increased GLS1 risk score correlated with overall survival in HNSCC patients [HR: 1.215, 95% confidence interval (CI): 1.011–1.460, p = 0.038] (Fig. 2B), suggesting that GLS1 is a prognosis-associated gene for this cancer type.